|
|
|
|
|
|
Collaboration and Licensing |
| |
|
| |
We base InSight's success on our wide portfolio of high quality products and the added value of our partners.
As we believe in long term partnerships and mutual benefits, we seek strategic partners for the following programs:
BiosimilarsInnovations
| • |
Small-molecule anti-cancer NCE drugs |
| • |
Heparanase-detection ELISA |
| • |
Site-specific PEGylation |
|
| |
|
|
|
